Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 3Phase 1 3

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 110Carcinoma, Intraductal, Noninfiltrating 7Breast Carcinoma In Situ 6Neoplasms 4Neoplasm Metastasis 3Inflammatory Breast Neoplasms 3Carcinoma, Ductal, Breast 3Breast Neoplasms, Male 3Infertility 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Breast Cancer Female 2Sleep Wake Disorders 1Quality of Life 1Pulmonary Fibrosis 1Prostatic Neoplasms 1Primary Breast Cancer 1Polycystic Ovary Syndrome 1Paget's Disease, Mammary 1Ovarian Neoplasms 1Obesity 1Neoplasm Recurrence, Local 1Liver Neoplasms 1Hot Flashes 1Fatigue 1Cardiotoxicity 1Carcinoma, Ovarian Epithelial 1Carcinoma, Lobular 1Carcinoma, Hepatocellular 1Breast Cancer Subjects 1

Interventions

exemestane 4Tamoxifen 3Paclitaxel 3Letrozole 3Goserelin 3Cyclophosphamide 3pegfilgrastim 2Radiotherapy 2Pyridoxine 2Leuprolide 2Fluorouracil 2Epirubicin 2Capecitabine 2Bevacizumab 2Anastrozole 2trastuzumab biosimilar HLX02 1ribociclib 1elacestrant 1Zoledronic Acid 1Trastuzumab 1Taxes 1Radiosurgery 1Prochlorperazine 1Palonosetron 1PF-05280014 1Ontruzant 1Ogivri 1Neoadjuvant Therapy 1Mometasone Furoate 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Breast Neoplasms, Male × Tamoxifen × Clear all
NCT06492616 2026-05-27

ELEGANT

Stemline Therapeutics, Inc.

Phase 3 Recruiting
4,220 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT01674140 2026-02-10

e3

SWOG Cancer Research Network

Phase 3 Active not recruiting
1,939 enrolled 15 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT01638247 2018-09-19

MALE

GBG Forschungs GmbH

Phase 3 Completed
56 enrolled
Breast

Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡